查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1889208

全球器官保存市场：预测至2032年－按保存方法、器官类型、溶液类型、设备类型、分销管道、最终用户和地区进行分析

Organ Preservation Market Forecasts to 2032 - Global Analysis By Preservation Method, Organ Type, Solution Type, Equipment Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球器官保存市场价值将达到 2.9811 亿美元，到 2032 年将达到 5.52 亿美元，预测期内复合年增长率为 9.2%。

器官保存是指在移植前，将捐赠的器官在体外保持功能和健康状态。它采用精确的冷却方法、保存液和创新技术，以减少细胞损伤并延缓代谢衰退。这些技术能够长期维持包括肾臟、肝臟、心臟和肺部在内的重要器官的功能，从而提高移植成功率和患者存活率。

根据美国人口普查局预测，到 2024 年，美国人口的 20% 将达到或超过 65 岁，这将导致与老龄化相关的疾病发生率增加，需要进行器官移植。

慢性病发生率呈上升趋势

在全球范围内，心臟病、肝损伤和糖尿病等慢性疾病的流行趋势正在推动对器官保存技术的需求。随着越来越多的患者发展到器官衰竭的严重阶段，器官移植的需求显着增加。这使得人们更加关注如何维持捐赠器官的长期活性。医学筛检的进步使得器官功能衰退的早期检测成为可能，从而鼓励更多患者接受移植治疗。同时，文明病的增加也给医疗保健系统带来了更大的压力。因此，慢性疾病的快速成长是推动器官保存市场发展的强劲动力。

可用捐赠器官严重短缺

儘管器官移植的需求持续成长，但器官捐赠率仍相对较低。许多器官因在摘取时不符合存活标准而被丢弃。这种限制减少了移植成功的案例，并减缓了技术应用的进步。许多国家仍面临严重的捐赠者短缺问题，可移植器官供不应求继续阻碍整个市场的发展。

长期保存技术的发展

器官长期保存方法的出现带来了巨大的市场前景。诸如机械灌注和先进的冷冻保存技术等，正在重新定义器官保存标准。这些解决方案可以扩大适用于移植的器官供应量。私人公司和研究机构都在优先推进该领域的突破。延长保质期有助于改善移植网路中的运输和协调。因此，长期保存技术将成为未来发展的主要驱动力。

来自替代疗法的竞争

替代疗法透过减少对保存的捐赠器官的需求，正日益影响市场。包括组织工程在内的再生医学解决方案正在提供新的治疗途径。人工器官的研发也在快速推进。这些创新最终可能会降低多种疾病领域对器官移植的需求。患者和临床医生正越来越多地探索创伤较小的治疗方案。因此，替代技术的广泛应用可能会限制未来的市场成长。

新冠疫情的感染疾病：

疫情对器官移植手术和捐赠者物流造成了严重干扰。许多医疗机构取消了手术，优先救治重症患者。这些干扰也阻碍了保存材料的采购。同时，疫情凸显了可靠保存方法的重要性。因此，先进且灵活的保存工具的研发速度加快。随着医疗系统的逐步稳定，市场正重获成长动力。

在预测期内，静态冷冻保存（SCS）细分市场将占据最大的市场份额。

由于其成熟的技术应用和广泛的普及，静态冷冻保存（SCS）预计将在预测期内占据最大的市场份额。它仍然是全球保存重要器官的主要方法。其经济性和易用性使其成为许多医疗机构的实用选择。其简便的操作也便于医护人员持续使用。新型保存液配方的不断涌现进一步提升了其性能。

在预测期内，研究和学术机构领域将实现最高的复合年增长率。

在预测期内，研究和学术机构领域预计将实现最高成长率，这主要得益于对技术进步的关注。对实验室保存创新技术的持续投入正在推动这一领域的扩张。这些机构处于评估和改进新型保存工具的前沿，它们的努力为产业商业性突破奠定了坚实的基础。与产业领导者的合作进一步增强了开发平臺。

占比最大的地区：

由于北美拥有完善的医疗保健体系，预计在预测期内，北美将占据最大的市场份额。该地区每年进行大量的器官移植手术，公共和私人机构都在积极推广器官捐赠。器官保存技术的研究和开发尤其活跃，而完善的保险政策也为先进技术的普及提供了便利。

年复合成长率最高的地区：

由于医疗保健能力的不断提升，预计亚太地区在预测期内将呈现最高的复合年增长率。民众对器官捐赠的教育不断加强，提高了器官移植的准备。多个国家正在加大对现代化设备和保存工具的投资。该地区器官相关疾病病例的增加推动了市场需求。政府的支持性政策正在加速科技的应用。因此，亚太地区预计将实现最高的成长率。

免费客製化服务：

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
  • 分析材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球器官保存市场（依保存方法划分）

  • 静态冷藏（SCS）
  • 冷冻保存和玻璃化
  • 低温机械灌注（HMP）
  • 亚常温灌注
  • 常温机械灌注（NMP）

6. 全球器官保存市场（依器官类型划分）

  • 肾
  • 角膜
  • 肝
  • 胰臟
  • 心
  • 肺
  • 其他组织

7. 全球器官保存市场（依解决方案类型划分）

  • 威斯康辛大学 (UW) 解决方案
  • Perfedex 和其他肺部保存液
  • CustodioIol HTK
  • Celsiol溶液
  • 器官特异性保存液

8. 全球器官保存市场（依设备类型划分）

  • 器官运输装置
  • 灌注装置
  • 冷藏储物容器
  • 携带式器官治疗系统

9. 全球器官保存市场（依分销管道划分）

  • 直接竞标
  • 零售/批发
  • 在线的

第十章 全球器官保存市场（依最终用户划分）

  • 医院及移植中心
  • 器官和组织库
  • 研究和学术机构
  • 生物技术和製药公司
  • 其他最终用户

第十一章 全球器官保存市场（依地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十三章：企业概况

  • TransMedics
  • XVIVO Perfusion AB
  • OrganOx Ltd
  • Getinge AB
  • Organ Recovery Systems
  • CryoLife, Inc.
  • BioLife Solutions, Inc.
  • Cryoport Systems, Inc.
  • Terumo Corporation
  • Dr. Franz Kohler Chemie GmbH
  • 21st Century Medicine
  • Vascular Perfusion Solutions, Inc.
  • Waters Medical Systems
  • Lifeline Scientific, Inc.
  • Preservation Solutions, Inc.
Product Code: SMRC32668

According to Stratistics MRC, the Global Organ Preservation Market is accounted for $298.11 million in 2025 and is expected to reach $552.00 million by 2032 growing at a CAGR of 9.2% during the forecast period. Organ preservation is the practice of keeping donated organs functional and healthy outside the body before they are transplanted. It uses precise cooling methods, preservation fluids, and innovative technologies to reduce cellular damage and delay metabolic decline. These techniques help critical organs including kidneys, livers, hearts, and lungs remain in good condition for longer periods, increasing their success in transplantation procedures and enhancing survival rates for patients in need.

According to the U.S. Census Bureau, it is projected that 20% of the U.S. population will be aged 65 and older by 2024, leading to a higher incidence of age-related diseases necessitating organ transplants.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

Chronic illnesses including heart disease, liver damage, and diabetes are becoming more common globally, fueling demand for organ preservation technologies. With more individuals reaching critical stages of organ failure, transplantation needs are increasing significantly. This has intensified the focus on maintaining donor organ viability for longer durations. Enhanced medical screening is enabling earlier detection of organ decline, pushing more patients toward transplant pathways. Rising lifestyle-related conditions are simultaneously adding pressure on healthcare systems. Consequently, the surge in chronic diseases is strongly propelling the organ preservation market.

Restraint:

Critical shortage of viable donor organs

While transplant requirements continue to escalate, organ donation remains comparatively low. A large number of organs are discarded because they fail to meet viability standards upon retrieval. This limitation reduces the number of successful transplant surgeries and slows technology uptake. Many countries still experience substantial gaps in donor contributions. Thus, the limited availability of transplant-ready organs continues to hinder overall market progress.

Opportunity:

Development of long-term preservation methods

The emergence of methods capable of maintaining organs for extended durations is opening strong prospects for the market. Technologies such as machine perfusion and advanced cryogenic storage are redefining preservation standards. These solutions can enlarge the pool of organs deemed suitable for transplantation. Both private companies and research institutions are prioritizing breakthroughs in this field. Enhanced preservation times support better transportation and coordination across transplant networks. As a result, long-term preservation technologies represent a key driver of future expansion.

Threat:

Competition from alternative treatments

Alternative therapies are increasingly influencing the market by reducing the need for preserved donor organs. Regenerative medicine solutions, including tissue engineering, are providing new pathways for treatment. Artificial organ development is continuing to advance at a rapid pace. Such innovations may eventually decrease transplant requirements in several disease areas. Patients and clinicians are gradually exploring less invasive treatment choices. Thus, the availability of substitutional technologies may limit future market growth.

Covid-19 Impact:

The pandemic caused major interruptions in transplant operations and donor logistics. Numerous centers halted surgeries to prioritize critical COVID-19 cases. These disruptions also created gaps in the procurement of preservation supplies. At the same time, the situation emphasized the importance of reliable preservation practices. This resulted in accelerated development of advanced, flexible preservation tools. As healthcare systems stabilize, the market is experiencing renewed momentum.

The static cold storage (SCS) segment is expected to be the largest during the forecast period

The static cold storage (SCS) segment is expected to account for the largest market share during the forecast period, due to its proven success and widespread usage. It continues to serve as the primary method for preserving major organs globally. Affordability and accessibility make it a practical choice for numerous healthcare settings. Its straightforward application supports consistent use among medical practitioners. New formulations of preservation fluids are strengthening its performance.

The research & academic institutes segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the research & academic institutes segment is predicted to witness the highest growth rate, due to their focus on technological advancement. Rising investments in laboratory-based preservation innovations are supporting expansion. These organizations are at the forefront of evaluating and refining new preservation tools. Their work strengthens the foundation for commercial breakthroughs in the sector. Partnerships with industry leaders further enhance development pipelines.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to its well-established medical systems. The region performs a large number of organ transplants each year. Public and private initiatives are actively promoting organ donation. Research and development activities related to preservation technologies are particularly strong. Supportive coverage policies make advanced technologies more accessible.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to expanding medical capabilities. Greater public education on organ donation is enhancing transplant readiness. Investments in modern equipment and preservation tools are increasing across several nations. The region faces rising cases of organ-related diseases, which drive market needs. Supportive government policies are helping accelerate technology adoption. Hence, Asia Pacific is set to achieve the highest growth rate.

Key players in the market

Some of the key players in Organ Preservation Market include TransMed, XVIVO Perf, OrganOx Lim, Getinge A, Organ Rec, CryoLife I, BioLife So, Cryoport S, Terumo Co, Dr. Franz K, 21st Centu, Vascular P, Waters Me, Lifeline S, and Preservat.

Key Developments:

In October 2025, OrganOx Ltd. announced the completion of its acquisition by Terumo Corporation, following satisfaction of all customary regulatory and closing conditions. OrganOx is now a wholly owned subsidiary of Terumo, positioning the company to unlock new opportunities to evolve its technology and reach more patients worldwide.

In September 2024, XVIVO Perfusion AB has entered into an agreement to acquire the transplant clinical workflow automation business, which includes, among other things, the development and distribution of the FlowHawkTM software platform, from Healthtech Solutions Inc. dba OmniLife. Organ transplantation is a complex, life-dependent process where flawless communication, both internal and external, is critical for transplant centers and the transplant ecosystem.

Preservation Methods Covered:

  • Static Cold Storage (SCS)
  • Cryopreservation & Vitrification
  • Hypothermic Machine Perfusion (HMP)
  • Subnormothermic Perfusion
  • Normothermic Machine Perfusion (NMP)

Organ Types Covered:

  • Kidney
  • Cornea
  • Liver
  • Pancreas
  • Heart
  • Lung
  • Other Tissues

Solution Types Covered:

  • University of Wisconsin (UW) Solution
  • Perfadex & Other Lungs Solutions
  • Custodiol HTK
  • Celsior Solution
  • Organ-Specific Specialized Solutions

Equipment Types Covered:

  • Organ Transport Devices
  • Perfusion Machines
  • Cold Storage Containers
  • Portable Organ Care Systems

Distribution Channels Covered:

  • Direct Tender
  • Retail/Wholesale
  • Online

End Users Covered:

  • Hospitals & Transplant Centers
  • Organ Banks & Tissue Banks
  • Research & Academic Institutes
  • Biotech & Pharma Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Organ Preservation Market, By Preservation Method

  • 5.1 Introduction
  • 5.2 Static Cold Storage (SCS)
  • 5.3 Cryopreservation & Vitrification
  • 5.4 Hypothermic Machine Perfusion (HMP)
  • 5.5 Subnormothermic Perfusion
  • 5.6 Normothermic Machine Perfusion (NMP)

6 Global Organ Preservation Market, By Organ Type

  • 6.1 Introduction
  • 6.2 Kidney
  • 6.3 Cornea
  • 6.4 Liver
  • 6.5 Pancreas
  • 6.6 Heart
  • 6.7 Lung
  • 6.8 Other Tissues

7 Global Organ Preservation Market, By Solution Type

  • 7.1 Introduction
  • 7.2 University of Wisconsin (UW) Solution
  • 7.3 Perfadex & Other Lungs Solutions
  • 7.4 Custodiol HTK
  • 7.5 Celsior Solution
  • 7.6 Organ-Specific Specialized Solutions

8 Global Organ Preservation Market, By Equipment Type

  • 8.1 Introduction
  • 8.2 Organ Transport Devices
  • 8.3 Perfusion Machines
  • 8.4 Cold Storage Containers
  • 8.5 Portable Organ Care Systems

9 Global Organ Preservation Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Direct Tender
  • 9.3 Retail/Wholesale
  • 9.4 Online

10 Global Organ Preservation Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Transplant Centers
  • 10.3 Organ Banks & Tissue Banks
  • 10.4 Research & Academic Institutes
  • 10.5 Biotech & Pharma Companies
  • 10.6 Other End Users

11 Global Organ Preservation Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 TransMedics
  • 13.2 XVIVO Perfusion AB
  • 13.3 OrganOx Ltd
  • 13.4 Getinge AB
  • 13.5 Organ Recovery Systems
  • 13.6 CryoLife, Inc.
  • 13.7 BioLife Solutions, Inc.
  • 13.8 Cryoport Systems, Inc.
  • 13.9 Terumo Corporation
  • 13.10 Dr. Franz Kohler Chemie GmbH
  • 13.11 21st Century Medicine
  • 13.12 Vascular Perfusion Solutions, Inc.
  • 13.13 Waters Medical Systems
  • 13.14 Lifeline Scientific, Inc.
  • 13.15 Preservation Solutions, Inc.

List of Tables

  • Table 1 Global Organ Preservation Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Organ Preservation Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 3 Global Organ Preservation Market Outlook, By Static Cold Storage (SCS) (2024-2032) ($MN)
  • Table 4 Global Organ Preservation Market Outlook, By Cryopreservation & Vitrification (2024-2032) ($MN)
  • Table 5 Global Organ Preservation Market Outlook, By Hypothermic Machine Perfusion (HMP) (2024-2032) ($MN)
  • Table 6 Global Organ Preservation Market Outlook, By Subnormothermic Perfusion (2024-2032) ($MN)
  • Table 7 Global Organ Preservation Market Outlook, By Normothermic Machine Perfusion (NMP) (2024-2032) ($MN)
  • Table 8 Global Organ Preservation Market Outlook, By Organ Type (2024-2032) ($MN)
  • Table 9 Global Organ Preservation Market Outlook, By Kidney (2024-2032) ($MN)
  • Table 10 Global Organ Preservation Market Outlook, By Cornea (2024-2032) ($MN)
  • Table 11 Global Organ Preservation Market Outlook, By Liver (2024-2032) ($MN)
  • Table 12 Global Organ Preservation Market Outlook, By Pancreas (2024-2032) ($MN)
  • Table 13 Global Organ Preservation Market Outlook, By Heart (2024-2032) ($MN)
  • Table 14 Global Organ Preservation Market Outlook, By Lung (2024-2032) ($MN)
  • Table 15 Global Organ Preservation Market Outlook, By Other Tissues (2024-2032) ($MN)
  • Table 16 Global Organ Preservation Market Outlook, By Solution Type (2024-2032) ($MN)
  • Table 17 Global Organ Preservation Market Outlook, By University of Wisconsin (UW) Solution (2024-2032) ($MN)
  • Table 18 Global Organ Preservation Market Outlook, By Perfadex & Other Lungs Solutions (2024-2032) ($MN)
  • Table 19 Global Organ Preservation Market Outlook, By Custodiol HTK (2024-2032) ($MN)
  • Table 20 Global Organ Preservation Market Outlook, By Celsior Solution (2024-2032) ($MN)
  • Table 21 Global Organ Preservation Market Outlook, By Organ-Specific Specialized Solutions (2024-2032) ($MN)
  • Table 22 Global Organ Preservation Market Outlook, By Equipment Type (2024-2032) ($MN)
  • Table 23 Global Organ Preservation Market Outlook, By Organ Transport Devices (2024-2032) ($MN)
  • Table 24 Global Organ Preservation Market Outlook, By Perfusion Machines (2024-2032) ($MN)
  • Table 25 Global Organ Preservation Market Outlook, By Cold Storage Containers (2024-2032) ($MN)
  • Table 26 Global Organ Preservation Market Outlook, By Portable Organ Care Systems (2024-2032) ($MN)
  • Table 27 Global Organ Preservation Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 28 Global Organ Preservation Market Outlook, By Direct Tender (2024-2032) ($MN)
  • Table 29 Global Organ Preservation Market Outlook, By Retail/Wholesale (2024-2032) ($MN)
  • Table 30 Global Organ Preservation Market Outlook, By Online (2024-2032) ($MN)
  • Table 31 Global Organ Preservation Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Organ Preservation Market Outlook, By Hospitals & Transplant Centers (2024-2032) ($MN)
  • Table 33 Global Organ Preservation Market Outlook, By Organ Banks & Tissue Banks (2024-2032) ($MN)
  • Table 34 Global Organ Preservation Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
  • Table 35 Global Organ Preservation Market Outlook, By Biotech & Pharma Companies (2024-2032) ($MN)
  • Table 36 Global Organ Preservation Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.